Search | IOVS | ARVO Journals

Showing 1 – 20 of 32

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Pharmacogenetic Study of Response to Intravitreal Anti-VEGF Therapy for Macular Edema Associated with Retinal Vein Occlusion

Jyoti Lama; Yuyang Luo; Ingrid U Scott; Neal Oden; Paul VanVeldhuisen; Katie Huynh; Michael S Ip; Barbara A Blodi; Lucia Sobrin; Ayellet Segré

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2603.

ARVO Imaging in the Eye Conference Abstract July 2024

UWF FA characterization of nonperfusion Patterns in SCORE2

Mary Wilda; Kipp Morgan; Kristi Dohm; Jeong W Pak; Paul Van Veldhuisen; Neal Oden; Michael Ip; Scott Ingrid; Barbara Blodi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(9):PB0068.

ARVO Annual Meeting Abstract June 2024

Ultrawide Field Fluorescein Angiogram (UWF-FA) Perivascular Leakage in Retinal Vein Occlusion from SCORE2

Jack (Qiancheng) Wang; Justin Parks; Mary K Wilda; Jeong W Pak; Paul VanVeldhuisen; Neal Oden; Michael S Ip; Ingrid U Scott; Amitha Domalpally; Barbara A Blodi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1730.

ARVO Annual Meeting Abstract June 2024

Nonperfusion Patterns in Ultrawide Field Fluorescein Angiography (UWF FA) from SCORE2

Kristi Lynn Dohm; Kipp Roy Morgan; Mary K Wilda; Jeong W Pak; Paul VanVeldhuisen; Neal Oden; Michael S Ip; Ingrid U Scott; Barbara A Blodi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6302.

Retina June 2023

High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21

PDF

Nitish Mehta; Sachi Patil; Vikram Modi; Rachel Vardi; Kevin Liu; Rishi P. Singh; David Sarraf; Neal L. Oden; Paul C. VanVeldhuisen; Ingrid U. Scott; Michael S. Ip; Barbara A. Blodi; Yasha Modi
TAGS: central retinal vein occlusion, vision, spectral domain-optical coherence tomography, patient prognosis, macular edema, trees (plant)
Trans. Vis. Sci. Tech.. 2023; 12(6):21. https://doi.org/10.1167/tvst.12.6.21

Includes: Supplemental Content

ARVO Imaging in the Eye Conference Abstract June 2023

Assessing Disorganization of Retinal Inner Layers in Long Term Follow Up of SCORE2 Trial

Rachel Linderman; Jonathon Le; Barbara Blodi; Amitha Domalpally; Rick Voland; Paul VanVeldhuisen; Neal Oden; Michael S Ip; Ingrid Scott

Invest. Ophthalmol. Vis. Sci.. 2023; 64(9):PB0047.

ARVO Annual Meeting Abstract June 2023

Assessing Disorganization of Retinal Inner Layers in Long Term Follow Up of SCORE2 Trial

Jonathan B Le; Barbara A Blodi; Amitha Domalpally; Rick Voland; Paul VanVeldhuisen; Neal Oden; Michael S Ip; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1761.

ARVO Annual Meeting Abstract June 2023

Ultra Widefield Fluorescein Angiography (UWF FA) in Retinal Vein Occlusion: 5-Year Data using the Networc grid from the SCORE2 Trial

Mary K Wilda; Ellie Corkery; Barbara A Blodi; Michael S Ip; Ingrid U Scott; Paul VanVeldhuisen; Neal Oden

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1776.

ARVO Annual Meeting Abstract June 2022

Visit Adherence and Visual Acuity in SCORE2

Brian L VanderBeek; Yinxi Yu; Neal Oden; Paul C Van Veldhuisen; Barbara A Blodi; Michael S Ip; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2672.

ARVO Annual Meeting Abstract June 2022

Association Between Retinal Hemorrhage and Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)

Anthony Gjyzeli; Samuel Whittier; Amitha Domalpally; Barbara A Blodi; Ingrid U Scott; Michael S Ip; Neal Oden; Paul C Van Veldhuisen; Rick Voland; Sheila Watson; Adrian Au; David Sarraf

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1733 – F0193.

ARVO Annual Meeting Abstract June 2021

Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial

Steven Kymes; Neal L Oden; Paul C Van Veldhuisen; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2180.

ARVO Annual Meeting Abstract June 2021

Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the S tudy of CO mparative Treatments for RE tinal Vein Occlusion 2 (SCORE2).

Samuel A Whittier; Adrian Au; David Sarraf; Neal L Oden; Paul C Van Veldhuisen; Ingrid U Scott; Michael S Ip; Sheila Watson; Barbara Blodi; Amitha Domalpally

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3183.

ARVO Annual Meeting Abstract June 2021

Cluster analysis and phenotype-genotype assessment of geographic atrophy secondary to age-related macular degeneration in the Age-Related Eye Disease Study 2

Tiarnan D L Keenan; Neal L Oden; Elvira Agron; Traci E Clemons; Alice Henning; Lars Fritsche; Wai T Wong; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2942.

Articles March 2021

Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14

PDF

Tyler Etheridge; Ellen T. A. Dobson; Marcel Wiedenmann; Neal Oden; Paul VanVeldhuisen; Ingrid U. Scott; Michael S. Ip; Kevin W. Eliceiri; Barbara A. Blodi; Amitha Domalpally
TAGS: eye, retinal vein occlusion, spectral domain-optical coherence tomography, visual acuity
Trans. Vis. Sci. Tech.. 2021; 10(3):31. https://doi.org/10.1167/tvst.10.3.31

ARVO Annual Meeting Abstract June 2020

Association of Ellipsoid Zone Defect and Visual Acuity in Eyes with Macular Edema in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE 2)

Tyler Etheridge; Ellen T. Arena; Marcel Wiedenmann; Neal Oden; Paul Van Veldhuisen; Ingrid U Scott; Michael S Ip; Kevin Eliceiri; Barbara A Blodi; Amitha Domalpally

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1333.

ARVO Annual Meeting Abstract July 2019

Ellipsoid Zone Status and its Association with Visual Acuity in Eyes with Macular Edema in the S tudy of CO mparative Treatments for RE tinal Vein Occlusion 2 (SCORE 2)

Chandana Papudesu; Amitha Domalpally; Neal Oden; Paul VanVeldhuisen; Ingrid U Scott; Michael S Ip; Barbara A Blodi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2590.

ARVO Annual Meeting Abstract July 2018

SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6

Michael S Ip; Paul C VanVeldhuisen; Ingrid U Scott; Barbara A Blodi; Tom Ghuman; Carl W Baker; Neal L. Oden

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5971.

ARVO Annual Meeting Abstract September 2016

S tudy of CO mparative Treatments for RE tinal Vein Occlusion 2 (SCORE2): Baseline Characteristics of the SCORE2 Population

Ingrid U Scott; Paul VanVeldhuisen; Michael S Ip; Barbara A Blodi; Neal Oden; Maria Figueroa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5154.

ARVO Annual Meeting Abstract June 2015

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure after Intravitreal Triamcinolone Injection

Ahmad A Aref; Ingrid U Scott; Neal Oden; Michael S Ip; Barbara A Blodi; Paul C. Van Veldhuisen; The SCORE Study Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5813.

ARVO Annual Meeting Abstract April 2011

Reading Center OCT Evaluation of Partial Thickness Macular Holes in the Standard Care vs. COrticosteroid for Retinal Vein Occlusion (SCORE) Study

Barbara A. Blodi; Amitha Domalpally; Christina Kruse; Michael Ip; Ingrid U. Scott; Neal L. Oden; Paul VanVeldhuisen; SCORE Study Investigator Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2167.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Pharmacogenetic Study of Response to Intravitreal Anti-VEGF Therapy for Macular Edema Associated with Retinal Vein Occlusion

UWF FA characterization of nonperfusion Patterns in SCORE2

Ultrawide Field Fluorescein Angiogram (UWF-FA) Perivascular Leakage in Retinal Vein Occlusion from SCORE2

Nonperfusion Patterns in Ultrawide Field Fluorescein Angiography (UWF FA) from SCORE2

High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21

Assessing Disorganization of Retinal Inner Layers in Long Term Follow Up of SCORE2 Trial

Assessing Disorganization of Retinal Inner Layers in Long Term Follow Up of SCORE2 Trial

Ultra Widefield Fluorescein Angiography (UWF FA) in Retinal Vein Occlusion: 5-Year Data using the Networc grid from the SCORE2 Trial

Visit Adherence and Visual Acuity in SCORE2

Association Between Retinal Hemorrhage and Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)

Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial

Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the S tudy of CO mparative Treatments for RE tinal Vein Occlusion 2 (SCORE2).

Cluster analysis and phenotype-genotype assessment of geographic atrophy secondary to age-related macular degeneration in the Age-Related Eye Disease Study 2

Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14

Association of Ellipsoid Zone Defect and Visual Acuity in Eyes with Macular Edema in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE 2)

Ellipsoid Zone Status and its Association with Visual Acuity in Eyes with Macular Edema in the S tudy of CO mparative Treatments for RE tinal Vein Occlusion 2 (SCORE 2)

SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6

S tudy of CO mparative Treatments for RE tinal Vein Occlusion 2 (SCORE2): Baseline Characteristics of the SCORE2 Population

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure after Intravitreal Triamcinolone Injection

Reading Center OCT Evaluation of Partial Thickness Macular Holes in the Standard Care vs. COrticosteroid for Retinal Vein Occlusion (SCORE) Study

To View More...

You must be signed into an individual account to use this feature.